Inclusion of DAPAgliflozin, Sodium-Glucose Cotransporter-2 Inhibitor in order to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders within Affected person together with Refractory Cardiovascular Failure with Diminished Ejection Small percentage (Create DAPA test).